Evidence map›Paper›PMID 35743757›Full record

ReviewJournal of personalized medicine2022

Coenzyme Q10 and Parkinsonian Syndromes: A Systematic Review.

Félix Javier Jiménez-Jiménez, Hortensia Alonso-Navarro, Elena García-Martín, José A G Agúndez

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Neuroprotection in Parkinson Disease.Neurology and therapy · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Understanding coenzyme Q.Physiological reviews · 2024
    Review
  10. Review
  11. Primary Coenzyme Q10 Deficiency-Related Ataxias.Journal of clinical medicine · 2024
    Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Félix Javier Jiménez-JiménezSection of Neurology, Hospital Universitario del Sureste, Ronda del Sur 10, E28500 Arganda del Rey, Spain.ORCID 0000-0002-7558-7323
Hortensia Alonso-NavarroSection of Neurology, Hospital Universitario del Sureste, Ronda del Sur 10, E28500 Arganda del Rey, Spain.
Elena García-MartínARADyAL Instituto de Salud Carlos III, University Institute of Molecular Pathology Biomarkers, Universidad de Extremadura, E10071 Cáceres, Spain.
José A G AgúndezARADyAL Instituto de Salud Carlos III, University Institute of Molecular Pathology Biomarkers, Universidad de Extremadura, E10071 Cáceres, Spain.ORCID 0000-0001-6895-9160
Hospital Universitario del Sureste · ESInstituto de Salud Carlos III · ES

Funding

Instituto de Salud Carlos III PI18/00540Instituto de Salud Carlos III PI21/01683Instituto de Salud Carlos III RETICS RD16/0006/0004 (ARADyAL)Junta de Extremadura, Mérida, Spain GR21073Junta de Extremadura, Mérida, Spain IB20134
6 · The paper itself

Abstract

Coenzyme Q

Indexed as

coenzyme Q10Lewy body dementiamultiple system atrophyParkinson’s diseaseprogressive supranuclear palsytherapeuticstissue concentrations

Identifiers

PMID35743757
PMCPMC9225264
OpenAlexW4283019362

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.